Tempest Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TPST | PCSA | ATORX.ST | ALLR | LTRN | RKV.V | |
|---|---|---|---|---|---|---|
| Market cap | 9.26M | 5.41M | 38.54M | 17.18M | 8.76M | 4.27M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.4 | -0.5 | -0.1 | -1.3 | -0.3 | — |
| Price/book | -6.8 | -17.0 | 0.3 | 4.9 | -2.3 | -2.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −95.15% | −75.51% | −99.44% | −2.70% | −82.53% | +2.94% |
| Today | −1.13% | −0.26% | +0.93% | −4.42% | −2.61% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TPST news ›Tempest Therapeutics, Inc. Announces Appointment of Nancy Freda-Smith as Director and Chair of the Audit Committee
She is a Certified Public Accountant and Certified Fraud Examiner. Ms. Freda-Smith also holds a Bachelor of Science in Accounting from Boston College. Luxury Shoppers Put Value Ahead of Labels September 14, 2026 at 07:16 am EDT Ralph…
Tempest Therapeutics (NASDAQ:TPST) Stock Lifted to Hold by Wall Street Zen
Posted by Kim Johansen on Oct 25th, 2026 Wall Street Zen upgraded shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday morning,Wall Street Zen…
More from 1 other outlet
Tempest Therapeutics plans Nov. 9 stock issuance vote
PIPE approval would trigger exercisability of the Series C and Series D Warrants, with their terms measured from the later of approval or registration effectiveness. Tempest Therapeutics, Inc. is seeking stockholder votes at its virtual…
Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise
GreenPower Announces Receipt of Letter from NASDAQ Tempest Therapeutics (TPST) has appointed John W. Frederick to its board of directors, adding an executive with financial and capital markets experience. Tempest Therapeutics (TPST) has…
Tempest Therapeutics sells $7.5M warrant offering
VodafoneZiggo Receives EU Commission Clearance For Tower Sale Separate warrant compensation is exercisable upon stockholder approval, with a stated purchase price of $1.0063 per share. The filing reports a cash placement fee equal to 7.0%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net3
- defenseworld.net1
- globenewswire.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.